APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosaRaymond J. Cho, Andrew P. South, Joya Sahu et al.|Science Translational Medicine|2018Cited by 132
Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinomaStephen A. Watt, Andrew P. South|Oncogene|2011Cited by 77
Thrombospondin-1 Is a Major Activator of TGF-β Signaling in Recessive Dystrophic Epidermolysis Bullosa FibroblastsVelina S. Atanasova, Andrew P. South|Journal of Investigative Dermatology|2019Cited by 71
Exosome-mediated transfer from the tumor microenvironment increases TGFβ signaling in squamous cell carcinoma.Lucia R. Languino, Andrew P. South|PubMed|2016Cited by 70
Trametinib-Induced Epidermal Thinning Accelerates a Mouse Model of Junctional Epidermolysis BullosaGrace Tartaglia, Andrew P. South|Biomolecules|2023Cited by 2